.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Federal Trade Commission
Citi
McKesson
Queensland Health
QuintilesIMS
US Army
Teva
Novartis

Generated: June 28, 2017

DrugPatentWatch Database Preview

Sumatriptan - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sumatriptan and what is the scope of sumatriptan freedom to operate?

Sumatriptan
is the generic ingredient in nine branded drugs marketed by Glaxosmithkline, Lannett, Teva Pharms Usa, Injectalia, Sagent Strides, Teva Parenteral, Antares Pharma Inc, Mylan Labs Ltd, West-ward Pharms Int, Dr Reddys Labs Ltd, Aurobindo Pharma, Par Pharm, Watson Labs, Endo Ventures Ltd, Fresenius Kabi Usa, Teva, Sagent Agila, Roxane, Mylan, Dr Reddys Labs Inc, Sun Pharm Inds Ltd, Aurobindo Pharma Ltd, Sun Pharma Global, Apotex Inc, Sandoz Inc, Par Sterile Products, Sandoz, Meridian Medcl, Teva Branded Pharm, Hikma Farmaceutica, Orchid Hlthcare, Wockhardt, Sun Pharm Inds, Hikma Pharms, and Avanir Pharms, and is included in forty-one NDAs. There are thirty-seven patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for sumatriptan. Four suppliers are listed for this compound. There are seven tentative approvals for this compound.

Summary for Generic Name: sumatriptan

Tradenames:9
Patents:37
Applicants:35
NDAs:41
Drug Master File Entries: see list23
Suppliers / Packagers: see list4
Bulk Api Vendors: see list36
Clinical Trials: see list94
Patent Applications: see list5,777
Therapeutic Class:Antimigraine Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:sumatriptan at DailyMed

Tentative approvals for SUMATRIPTAN

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 25MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 100MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 50MG BASETABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm
ZECUITY
sumatriptan succinate
SYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo7,973,058► Subscribe ► Subscribe
Endo Ventures Ltd
SUMAVEL DOSEPRO
sumatriptan succinate
INJECTABLE;SUBCUTANEOUS022239-001Jul 15, 2009BXRXYesYes6,280,410► SubscribeY ► Subscribe
Watson Labs
SUMATRIPTAN SUCCINATE
sumatriptan succinate
TABLET;ORAL076933-001Aug 10, 2009ABRXNoNo► Subscribe► Subscribe
Hikma Pharms
SUMATRIPTAN SUCCINATE
sumatriptan succinate
TABLET;ORAL078298-002May 21, 2013DISCNNoNo► Subscribe► Subscribe
Sagent Agila
SUMATRIPTAN SUCCINATE
sumatriptan succinate
INJECTABLE;SUBCUTANEOUS090641-001Jul 28, 2010APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sumatriptan

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-003Aug 26, 19975,554,639*PED► Subscribe
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-003Aug 26, 19975,705,520*PED► Subscribe
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-001Aug 26, 19975,554,639*PED► Subscribe
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-003Aug 26, 19974,816,470*PED► Subscribe
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-002Aug 26, 19974,816,470*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Argus Health
Accenture
Cipla
Johnson and Johnson
Boehringer Ingelheim
McKesson
Federal Trade Commission
AstraZeneca
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot